Belite Bio (BLTE) Equity Ratio (2021 - 2025)

Belite Bio has reported Equity Ratio for 5 years, with the latest figure at 0.99 in Q4 2025.

• For the quarter ending Q4 2025, Equity Ratio rose 2.98% year-over-year to 0.99; the trailing twelve-month figure through Dec 2025 stood at 0.99 (up 2.98% YoY), and the FY2025 full-year result was 0.99, up 2.98% from the prior year.
• Equity Ratio for Q4 2025 stood at 0.99, up from 0.96 in the prior quarter.
• The five-year high for Equity Ratio was 0.99 in Q4 2025, with the low at 0.82 in Q4 2021.
• Average Equity Ratio over 5 years is 0.6, with a median of 0.96 recorded in 2023.
• Year-over-year, Equity Ratio soared 213.95% in 2022 and increased 0.32% in 2024.
• Tracing BLTE's Equity Ratio over 5 years: stood at 0.82 in 2021, then soared by 213.95% to 0.94 in 2022, then climbed by 1.93% to 0.96 in 2023, then advanced by 0.32% to 0.96 in 2024, then grew by 2.98% to 0.99 in 2025.
• The last three Equity Ratio figures came in at 0.99 (Q4 2025), 0.96 (Q4 2024), and 0.96 (Q4 2023), per Business Quant data.

Peer Comparison